Suchergebnisse - "Pál, Adrián"

PubPharm (6)

1

Discovery of new diaryl ether inhibitors against Mycobacterium tuberculosis targeting the minor portal of InhA

enthalten in: European journal of medicinal chemistry | 2023

von Chebaiki, M. | Delfourne, E. | Tamhaev, R. | +15

2

Novel pyrimidine-1,3,4-oxadiazole hybrids and their precursors as potential antimycobacterial agents

enthalten in: Future medicinal chemistry | 2023

von Pflégr, V. | Stolaříková, J. | Pál, A. | +2

3

A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis

enthalten in: mSphere | 2022

von Salina, E. | Postiglione, U. | Chiarelli, L. | +13

4

Bioinformatic Mining and Structure-Activity Profiling of Baeyer-Villiger Monooxygenases from Mycobacterium tuberculosis

enthalten in: mSphere | 2022

von Tomas, N. | Leonelli, D. | Campoy, M. | +13

5

Design and Synthesis of Highly Active Antimycobacterial Mutual Esters of 2-(2-Isonicotinoylhydrazineylidene)propanoic Acid

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2021

von Pflégr, V. | Maixnerová, J. | Stolaříková, J. | +5

6

Design and synthesis of 2-(2-isonicotinoylhydrazineylidene)propanamides as InhA inhibitors with high antitubercular activity

enthalten in: European journal of medicinal chemistry | 2021

von Pflégr, V. | Horváth, L. | Stolaříková, J. | +5

1
[1]